Company Story and Identity

Who they are & When they started
Noom is a U.S.-based digital health company founded in 2008 by Saeju Jeong and Artem Petakov, and headquartered in New York City Reuters+14Wikipedia+14Wikipedia+14. From its start as a psychology-driven weight management app, Noom has grown into an expansive wellness platform rooted in behavior change.

Leadership and Vision
Saeju Jeong, co‑founder, now serves as Executive Chairman after transitioning from CEO in mid‑2023, with Geoff Cook stepping into the CEO role Wikipedia+1Wikipedia+2Clay+2. Their vision: blend psychological insight, digital tools, and clinical care to help people build sustainable habits from the inside out.

Funding History
Since its early days, Noom has raised over $600 million across multiple rounds, including a notable $540 million Series F round in 2021 that valued the company around $3.7 billion Built In NYC+5Wikipedia+5U.S. Chamber of Commerce+5Noom: Lose weight and keep it off.+9Tracxn+9Wikipedia+9.

Noom’s GLP-1 Program

Medications Offered

• Injectable GLP‑1s: semaglutide (Wegovy/Ozempic), tirzepatide (Zepbound/Mounjaro), and others like Saxenda, Victoza, Trulicity, Bydureon Noom: Lose weight and keep it off.+14Nutrition and Nourishment Collective+14Noom: Lose weight and keep it off.+14

• Oral GLP‑1s: Rybelsus ® YouTube+15Nutrition and Nourishment Collective+15Noom: Lose weight and keep it off.+15

• Other oral meds: metformin, Contrave®, Topiramate® AP News+3Nutrition and Nourishment Collective+3Noom: Lose weight and keep it off.+3

• Compounded GLP‑1s: personalized semaglutide formulated in micro‑doses—offered to improve tolerance and reduce cost Noom: Lose weight and keep it off.+4Reuters+4Axios+4

Notable Features

• Microdose approach: Starting at a lower dose (e.g., half of the typical 0.25 mg starter) and ramping slowly helps many users experience fewer side effects and stronger adherence Reuters. Noom’s microdose clients reportedly lose up to 11 pounds in one month and 17 pounds in two months, with 70% reporting no side effects AJMC+15pharmaphorum+15hers+15.

• Holistic combination: The GLP‑1 medications are paired with Noom’s time-tested psychology‑based curriculum, aimed at creating lasting shifts in habits Wikipedia+14Noom: Lose weight and keep it off.+14Nutrition and Nourishment Collective+14.

Pricing & Plans

• Microdose GLP‑1 Rx Program: starts at approximately $119 per month with medical oversight and flexible dosing Nutrition and Nourishment Collective+3Noom: Lose weight and keep it off.+3Noom: Lose weight and keep it off.+3.

• Compounded GLP‑1 Rx: $149 trial (≈21 days), then $837 every three months ($279/month) Nutrition and Nourishment Collective.

• Weight‑Loss Pill Program (e.g., metformin): $69 trial, then $297 per three‑month cycle ($99/month) Nutrition and Nourishment Collective+1.

• Branded Meds Plan: $69 first month, then $297 per quarter ($99/month)—meds are filled separately, typically via insurance Nutrition and Nourishment Collective+1.

Insurance & Flexibility

• Subscription fees cannot be paid with insurance, but Noom helps coordinate insurance for medication costs when possible. HSA/FSA use is permitted Nutrition and Nourishment Collective.

How It Works

• Step-by-Step: After completing a brief intake survey, you undergo lab testing (covered in most states), meet with a licensed clinician via video, begin your tailored GLP‑1 treatment, and receive ongoing support—all through Noom’s app Noom: Lose weight and keep it off.+1.

• Continuity of Care: Includes unlimited messaging and telehealth with your care team, refill coordination, side‑effect management, and access to the Noom GLP‑1 Companion—a structured, behavior-focused support program inside the app Reuters+13Nutrition and Nourishment Collective+13Noom: Lose weight and keep it off.+13.

Customer Experience

• Platform Usability: Noom is user-friendly, warm, and structured—many people feel welcomed and supported.

• App Features: Includes nutrition and workout tracking, the Muscle Defense™ video series, side‑effect guidance, quizzes, peer communities, and GLP‑1 education modules Nutrition and Nourishment Collective+1.

• Feedback & Ratings: Mixed to positive. On Trustpilot, ratings hover around 3.5/5. Common praise includes the integration of meds with habit-building tools; concerns often relate to billing or support response times Nutrition and Nourishment Collective.

Medical Support & Safety

• Clinical Oversight: Every program includes evaluation by licensed clinicians, lab oversight, and personalized prescriptions based on medical need Noom: Lose weight and keep it off.+1.

• Safety & Side Effects: Microdosing is designed to ease side‑effect burden. The app provides tools and guidance to manage usual GI symptoms and monitor progress pharmaphorumNoom: Lose weight and keep it off..

• Contraindications: Intake surveys and lab testing help screen for who is safe to use GLP‑1s.

Shipping & Delivery

• Compounded GLP‑1s or pills ship directly to your door—usually within a week of prescription ⁠—streamlining access and convenience Barron's+3Nutrition and Nourishment Collective+3Noom: Lose weight and keep it off.+3.

Credibility & Compliance

• Regulatory Sensitivity: Noom operates within evolving FDA guidelines, especially about compounding. Their microdose model is positioned to comply with personalized care exceptions, though the space is under regulatory scrutiny Reuters.

• Research-Based Approach: Noom’s programs are grounded in behavioral psychology and supported by studies—users combining Noom with GLP‑1s report up to six times more weight loss at 12 months than with meds alone Noom: Lose weight and keep it off.+1.

• Recognitions: Noom was the first mobile app certified by the CDC as a diabetes prevention program (2017) Wikipedia.

Recent Updates & Developments

• Noom has recently introduced the microdose GLP‑1 package with promising early results in weight loss and tolerability pharmaphorum+1.

• As FDA rules tighten on mass compounding, Noom is pivoting strategically to offer personalized, small-dose options under current legal pathways Reuters.

Final Thoughts

Noom richly blends GLP-1 pharmacotherapy with habit-centered coaching in a thoughtful, approachable way. It offers clear structure—and genuine warmth—in a single app. The microdose option shows both innovation and empathy, easing side effects while staying accessible. If you're looking for a solution that treats weight loss with both science and heart, Noom helps you feel supported every step of the way.